Add to ORKGRegulatory review time has been associated with post-market medication safety issues in the United States. Our objective was to evaluate whether regulatory review time and near deadline approval are associated with post-market safety events (PMSEs) for novel medicines approved by the European Medicines Agency (EMA)
In the United States, all newly developed drugs undergo a lengthy reviewprocess conducted by the US ...
In the United States, all newly developed drugs undergo a lengthy reviewprocess conducted by the US ...
In the United States, all newly developed drugs undergo a lengthy reviewprocess conducted by the US ...
Regulatory review time has been associated with post-market medication safety issues in the United S...
Regulatory review time has been associated with post-market medication safety issues in the United S...
The aim of the study is to describe preapproval safety concerns expressed by the European Medicines ...
The aim of the study is to describe preapproval safety concerns expressed by the European Medicines ...
The aim of the study is to describe preapproval safety concerns expressed by the European Medicines ...
The aim of the study is to describe preapproval safety concerns expressed by the European Medicines ...
With the recent withdrawal of Vioxx and other high-profile products, there have been increasing conc...
Importance: Ensuring patients have access to safe and efficacious medicines in a timely manner is an...
Food and Drug Administration (FDA) review times have significantly declined under the user-fee regim...
Background: Novel therapies are transforming cancer care. Regulatory review and approval are essenti...
In the United States, all newly developed drugs undergo a lengthy reviewprocess conducted by the US ...
In the United States, all newly developed drugs undergo a lengthy reviewprocess conducted by the US ...
In the United States, all newly developed drugs undergo a lengthy reviewprocess conducted by the US ...
In the United States, all newly developed drugs undergo a lengthy reviewprocess conducted by the US ...
In the United States, all newly developed drugs undergo a lengthy reviewprocess conducted by the US ...
Regulatory review time has been associated with post-market medication safety issues in the United S...
Regulatory review time has been associated with post-market medication safety issues in the United S...
The aim of the study is to describe preapproval safety concerns expressed by the European Medicines ...
The aim of the study is to describe preapproval safety concerns expressed by the European Medicines ...
The aim of the study is to describe preapproval safety concerns expressed by the European Medicines ...
The aim of the study is to describe preapproval safety concerns expressed by the European Medicines ...
With the recent withdrawal of Vioxx and other high-profile products, there have been increasing conc...
Importance: Ensuring patients have access to safe and efficacious medicines in a timely manner is an...
Food and Drug Administration (FDA) review times have significantly declined under the user-fee regim...
Background: Novel therapies are transforming cancer care. Regulatory review and approval are essenti...
In the United States, all newly developed drugs undergo a lengthy reviewprocess conducted by the US ...
In the United States, all newly developed drugs undergo a lengthy reviewprocess conducted by the US ...
In the United States, all newly developed drugs undergo a lengthy reviewprocess conducted by the US ...
In the United States, all newly developed drugs undergo a lengthy reviewprocess conducted by the US ...
In the United States, all newly developed drugs undergo a lengthy reviewprocess conducted by the US ...